Impact of CYP2C19 Genotype Status on Clinical Outcomes in Patients with Symptomatic Coronary Artery Disease, Stroke, and Peripheral Arterial Disease: A Systematic Review and Meta-Analysis.

Dominique P M S M MaasLoes H WillemsJosephine KranendonkCornelis KramersMichiel C Warlé
Published in: Drugs (2024)
PROSPERO identifier no. CRD42020220284.